Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

Treatment with donanemab (Kisunla) raised the risk of amyloid-related imaging abnormalities (ARIA) in people with early ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Switzerland: A recent study published in JAMA Neurology has highlighted key factors influencing the recurrence of ...

PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

There is precedent for treating neurological conditions with implanted electrodes in the deep brain, but it requires a ...

A novel AI framework predicts traumatic brain injury severity from police reports, achieving over 94% accuracy by integrating ...

Of patients who had both sleep spindles and cognitive motor dissociation, 76% showed evidence of consciousness by the time ...

Brain bleeds double dementia risk—new study stresses early cognitive screening for better patient care. Read more now.

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.

Sudden cardiac arrest (SCA) can affect all ages, with varying causes for those under 35 and over. Early detection of symptoms such as dizziness, chest ...